Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2009-07-21
2011-12-27
Bristol, Lynn (Department: 1643)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S029000
Reexamination Certificate
active
08084222
ABSTRACT:
The present disclosure provides compositions and methods comprising cells producing glycoproteins with variant glycosylation patterns. The methods and compositions may be used in producing antibodies and proteins of therapeutic value.
REFERENCES:
patent: 6602684 (2003-08-01), Umana et al.
patent: 6737056 (2004-05-01), Presta
patent: 6946292 (2005-09-01), Kanda et al.
patent: 7393683 (2008-07-01), Kanda et al.
patent: 7416727 (2008-08-01), Presta
patent: 7425446 (2008-09-01), Kanda et al.
patent: 2004/0072290 (2004-04-01), Umana et al.
patent: 2005/0074843 (2005-04-01), Umana et al.
patent: 2005/0079605 (2005-04-01), Umana et al.
patent: 2005/0272128 (2005-12-01), Umana et al.
patent: 2005/0272916 (2005-12-01), Hanai et al.
patent: 2006/0064781 (2006-03-01), Kanda et al.
patent: 2006/0182741 (2006-08-01), Bourel et al.
patent: 2007/0015239 (2007-01-01), Bihoreau et al.
patent: 2008/0118501 (2008-05-01), Schindler et al.
patent: 2008/0280322 (2008-11-01), Umana et al.
patent: 2009/0285830 (2009-11-01), Adams et al.
patent: 2010/0081150 (2010-04-01), Liu et al.
patent: 2010/0081172 (2010-04-01), Liu et al.
patent: 2010/0081794 (2010-04-01), Liu et al.
patent: 2011/0059075 (2011-03-01), Wittrup et al.
patent: 1176195 (2002-01-01), None
patent: 1331266 (2003-07-01), None
patent: 1176195 (2005-03-01), None
patent: 1914244 (2008-04-01), None
patent: 1914244 (2008-06-01), None
patent: 2008113663 (2008-05-01), None
patent: WO 2005/012358 (2005-02-01), None
patent: WO 2005/040221 (2005-05-01), None
patent: WO 2005/012358 (2005-09-01), None
patent: WO 2006/014679 (2006-02-01), None
patent: WO 2006/014685 (2006-02-01), None
patent: WO 2006/133148 (2006-12-01), None
patent: WO 2007/028144 (2007-03-01), None
patent: WO 2007/029054 (2007-03-01), None
patent: WO 2007/048077 (2007-04-01), None
patent: WO 2006/133148 (2007-05-01), None
patent: WO 2007/053767 (2007-05-01), None
patent: WO 2007/028144 (2007-06-01), None
patent: WO 2007/048077 (2007-07-01), None
patent: WO 2007/084672 (2007-07-01), None
patent: WO 2007/084672 (2007-10-01), None
patent: WO 2007/146847 (2007-12-01), None
patent: WO 2007/146847 (2008-11-01), None
Jones et al (Biochem. Biophys. Acta 1726(2): 121-137 (2005).
Perkel et al. (Proc. Soc. Exp. Biol. Med. Mar. 1989;190 (3):286-93; Abstract).
Banerjee, et al. The evolution of N-glycan-dependent endoplasmic reticulum quality control factors for glycoprotein folding and degradation. Proc Natl Acad Sci U S A. Jul. 10, 2007;104(28):11676-81.
Culture medium definition. Dictionary.com. Accessed May 4, 2011.
Czlapinski, et al. Synthetic glycobiology: Exploits in the Golgi compartment. Curr Opin Chem Biol. Dec. 2006;10(6):645-51.
Delente, J. Glycosylation revisited. Trends in Biotechnology. 1985; 3(9):218.
Fermentor definition. Dictionary.com. Accessed May 4, 2011.
International search report dated Nov. 24, 2009 for PCT Application No. US2009/51325.
Lowe, et al. A genetic approach to Mammalian glycan function. Annu Rev Biochem. 2003;72:643-91.
Natsume, et al. Fucose removal from complex-type oligosaccharide enhances the antibody-dependent cellular cytotoxicity of single-gene-encoded bispecific antibody comprising of two single-chain antibodies linked to the antibody constant region. J Biochem. Sep. 2006;140(3):359-68.
Olden, et al. Carbohydrate moieties of glycoproteins. A re-evaluation of their function. Biochim Biophys Acta. May 12, 1982;650(4):209-32.
Sallustio, et al. Novel genetic instability associated with a developmentally regulated glycosyltransferase locus in Chinese hamster ovary cells. Somat Cell Mol Genet. Sep. 1989;15(5):387-400.
Shields, et al. Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity. J Biol Chem. Jul. 26, 2002;277(30):26733-40.
Shinkawa, et al. The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J Biol Chem. Jan. 2003. 31;278(5):3466-73.
Wright, et al. Antibody variable region glycosylation: biochemical and clinical effects. Springer Semin Immunopathol. 1993;15(2-3):259-73.
Yamane-Ohnuki, et al. Establishment of FUT8 knockout Chinese hamster ovary cells: an ideal host cell line for producing completely defucosylated antibodies with enhanced antibody-dependet cellular cytotoxicity. Biotechnol Bioeng. Sep. 5, 2004; 87(5):614-22.
Liu Cheng
Tai Wei Chan
Wang Pei
Xiang Jingyi
Yan Su
Bristol Lynn
Eureka Therapeutics, Inc.
Wilson Sonsini Goodrich & Rosati
LandOfFree
Methods for generating host cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for generating host cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for generating host cells will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4303864